SEC Form 4 · accession 0001093557-15-000026

DEXCOM INC · DXCM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Sr. VP, General Counsel

Period of report

Feb 9, 2015

Accepted (ET)

Feb 11, 2015 · 8:06 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001093557

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 9, 2015	M	2,587	$8.85	A	112,605	D
Common Stock^F1,F2,F3	Feb 9, 2015	S	2,587	$61.6577	D	110,018	D
Common Stock	Feb 9, 2015	M	2,452	$4.58	A	112,470	D
Common Stock^F1,F2,F3	Feb 9, 2015	S	2,452	$61.6577	D	110,018	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)	$4.58	Feb 9, 2015	M	2,452	D	May 19, 2010	May 19, 2019	Common Stock	2,452	0	D
Non-Qualified Stock Option (right to buy)	$8.85	Feb 9, 2015	M	2,587	D	Jan 14, 2009	Jan 14, 2018	Common Stock	2,587	12,474	D

F1On December 5, 2014, Mr. Lister adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Lister. The shares set forth above were sold pursuant to the 10b5-1 Plan.
F2This transaction was executed in multiple trades at prices ranging from $60.86 to $63.18. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
F3Included in this number are 88,021 unvested restricted stock units, 65,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017, 17,500 of which were granted on March 11, 2013 and shall vest through March 11, 2016, and 5,521 of which were granted on March 8, 2012 and shall vest through March 8, 2015.